BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 34533072)

  • 1. Women with Atypical Glandular Cells in Japan: The Clinical Significance and Utility of HPV-DNA Testing in Korean Women with Atypical Glandular Cells in Cervical Pap Tests.
    Kawase R; Suzuki S
    Cancer Invest; 2022 Mar; 40(3):234. PubMed ID: 34533072
    [No Abstract]   [Full Text] [Related]  

  • 2. Cervical cancer screening from Pap smear to human papillomavirus DNA testing.
    Jin XW; Xu H
    Compr Ther; 2001; 27(3):202-8. PubMed ID: 11569320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-risk human papillomavirus DNA testing: a marker for atypical glandular cells.
    Saqi A; Gupta PK; Erroll M; Babiac A; Blackmun D; Mansukhani M; Vazquez M
    Diagn Cytopathol; 2006 Mar; 34(3):235-9. PubMed ID: 16470857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of monitoring human papillomavirus DNA results for Papanicolaou tests diagnosed as atypical squamous cells of undetermined significance: a College of American Pathologists Q-Probes study of 68 institutions.
    Tworek JA; Jones BA; Raab S; Clary KM; Walsh MK
    Arch Pathol Lab Med; 2007 Oct; 131(10):1525-31. PubMed ID: 17922588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glandular Lesions of the Cervix in Clinical Practice: A Cytology, Histology, and Human Papillomavirus Correlation Study From 2 Institutions.
    Miller RA; Mody DR; Tams KC; Thrall MJ
    Arch Pathol Lab Med; 2015 Nov; 139(11):1431-6. PubMed ID: 25951104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPV testing in liquid specimens.
    Geyer SJ
    Acta Cytol; 2006; 50(5):599-600. PubMed ID: 17017457
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of initial stream urine samples and cervical samples for detection of human papillomavirus.
    Hagihara M; Yamagishi Y; Izumi K; Miyazaki N; Suzuki T; Kato H; Nishiyama N; Koizumi Y; Suematsu H; Mikamo H
    J Infect Chemother; 2016 Aug; 22(8):559-62. PubMed ID: 27342077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The age-specific relationships of abnormal cytology and human papillomavirus DNA results to the risk of cervical precancer and cancer.
    Castle PE; Fetterman B; Thomas Cox J; Shaber R; Poitras N; Lorey T; Kinney W
    Obstet Gynecol; 2010 Jul; 116(1):76-84. PubMed ID: 20567171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Clinical Significance and Utility of HPV-DNA Testing in Korean Women with Atypical Glandular Cells in Cervical Pap Tests: An Analysis of 311 Cases at a Single Institution.
    Jang TK; Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    Cancer Invest; 2021 Nov; 39(10):885-892. PubMed ID: 34279158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of human papillomavirus DNA in routine cervical scraping samples: use for a national cervical cancer screening program in a developing nation.
    Othman N; Othman NH
    Asian Pac J Cancer Prev; 2014; 15(5):2245-9. PubMed ID: 24716964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papilloma virus testing knowledge and attitudes among women attending colposcopy clinic with ASCUS/LGSIL pap smears.
    Le T; Hicks W; Menard C; Boyd D; Hewson T; Hopkins L; Kee Fung MF
    J Obstet Gynaecol Can; 2004 Sep; 26(9):788-92. PubMed ID: 15361273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical cancer screening today. The role of HPV DNA testing.
    Berman NR
    Adv Nurse Pract; 2006 Apr; 14(4):24-9; quiz 30. PubMed ID: 16972469
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevalence of human papillomavirus genotype among Moroccan women during a local screening program.
    Alhamany Z; El Mzibri M; Kharbach A; Malihy A; Abouqal R; Jaddi H; Benomar A; Attaleb M; Lamalmi N; Cherradi N
    J Infect Dev Ctries; 2010 Nov; 4(11):732-9. PubMed ID: 21252451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary HPV DNA testing as a tool for cervical cancer screening in women who are reluctant to have a Pap smear in France.
    Lefeuvre C; Pivert A; Guillou-Guillemette HL; Lunel-Fabiani F; Veillon P; Le Duc-Banaszuk AS; Ducancelle A
    J Infect; 2020 Aug; 81(2):248-254. PubMed ID: 32413363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cervical cancer screning: from cytology to HPV testing].
    Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):289-292. PubMed ID: 31154708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knowledge and attitudes about human papillomavirus, Pap smears, and cervical cancer among young women in Brazil: implications for health education and prevention.
    Moreira ED; Oliveira BG; Ferraz FM; Costa S; Costa Filho JO; Karic G
    Int J Gynecol Cancer; 2006; 16(2):599-603. PubMed ID: 16681732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of atypical squamous cell of undetermined significance cervical cytology with high-risk human papilloma virus genotypes.
    Musa J; Taiwo B; Goldsmith S; Sutton S; Berzins B; Murphy RL
    Arch Gynecol Obstet; 2011 Feb; 283(2):343-8. PubMed ID: 20229315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of HPV testing in clinical practice.
    Cuzick J
    Virus Res; 2002 Nov; 89(2):263-9. PubMed ID: 12445665
    [No Abstract]   [Full Text] [Related]  

  • 19. Type-Specific Identification of Genital Human Papillomavirus Infection in Women with Cytological Abnormality.
    Vargas H; Sánchez JP; Guerrero ML; Ortiz LT; Rodríguez DM; Amaya J; Diaz LP; Gómez SL; Golijow C
    Acta Cytol; 2016; 60(3):211-6. PubMed ID: 27215608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical cancer, Pap smear and HPV testing: an update of the role of organized Pap smear screening and HPV testing.
    Sigurdsson K
    Acta Obstet Gynecol Scand; 1999 Jul; 78(6):467-77. PubMed ID: 10376855
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.